Comment on Petri Dish: IPO-bound drugmaker strikes BioMarin deal, plus other biotech news

Petri Dish: IPO-bound drugmaker strikes BioMarin deal, plus other biotech news

In this week's edition of Petri Dish, a Boston cancer biotech is on the hunt for a new CFO, a startup has signed a deal ahead of its IPO and a cancer drug developer raised $175 million.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News